Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.

Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M

DOI: 10.1007/s13555-025-01362-w
Published: 2025 Apr
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01362-w,
  title = {Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.},
  author = {Armstrong AW and Kircik L and Stein Gold L and Strober B and De Oliveira CHMC and Vaile J and Jou YM and Daamen C and Scharnitz T and Lebwohl M},
  year = {2025},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-025-01362-w},
  url = {https://doi.org/10.1007/s13555-025-01362-w}
}

RIS

TY  - JOUR
TI  - Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.
AU  - Armstrong AW
AU  - Kircik L
AU  - Stein Gold L
AU  - Strober B
AU  - De Oliveira CHMC
AU  - Vaile J
AU  - Jou YM
AU  - Daamen C
AU  - Scharnitz T
AU  - Lebwohl M
PY  - 2025
JO  - Dermatology and therapy
DO  - 10.1007/s13555-025-01362-w
UR  - https://doi.org/10.1007/s13555-025-01362-w
ER  -

APA

AW, A., L, K., L, S. G., B, S., CHMC, D. O., J, V., YM, J., C, D., T, S., & M, L. (2025). Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01362-w

Source records

pubmed · retrieved 2026-09-25T08:50:28.229Z